It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...

A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...

A simple online search for semaglutide, the active ingredient in Ozempic or Wegovy, can lead consumers down a rabbit ... but some of those deals come with a potentially deadly cost. U.S. consumers pay ...

A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

The demand for weight loss drugs like Ozempic and Wegovy has led to a flood of fake drugs hitting the market. However, these ...

Wegovy and Ozempic drove Novo Nordisk to record bumper sales ... the real winner will likely be the company that offers the ...

New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

Nearly three-quarters of U.S. adults are overweight or obese, according to a sweeping new study. The findings have ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...